What experts need you to know about the MMR vaccine
What experts need you to know about the MMR vaccine
Show Caption
Hide Caption
Here is what to know about measles symptoms, spread and vaccine
Cases of the measles are on the rise. Here's what you should know about how measles are spread, its symptoms and the MMR vaccine.
As the U.S. continues to battle the largest spike in measles cases since 2019, experts underscore the importance of MMR vaccinations to prevent the spread of measles and bolster collective immunity.
Measles is a highly infectious, life-threatening viral disease that infects the respiratory tract. Before the measles vaccine was introduced in 1963, it is estimated that 3 to 4 million people in the U.S. contracted measles every year, causing 500 deaths and 48,000 hospitalizations annually, according to the U.S. Centers for Disease Control & Prevention.
The MMR vaccine, a combination vaccine that protects against measles, mumps and rubella, has been instrumental in curtailing the spread of measles. The vaccine has been available in its current form since 1971, marking more than 50 years of safe and effective use.
What is the MMR vaccine?
The MMR vaccine is an attenuated vaccine, meaning it uses particles of live viruses to help generate the body's immune response and build antibodies, says Dr. Matthew Harris, a pediatric emergency medicine physician and medical director of clinical preparedness for Northwell Health. 'Everyone is encouraged to get it, because as we've seen in Texas and New Mexico, measles spreads like wildfire,' says Harris.
The MMR vaccine is highly effective. Most vaccinated people will not develop measles, mumps or rubella when they are exposed to the diseases. But, in the case a vaccinated person does develop one of these diseases, their symptoms are typically milder, and they are far less contagious, per the CDC.
'So much for MAHA': RFK Jr. MMR vaccine support spurs backlash
Is the MMR vaccine safe?
The MMR vaccine is very safe, says Harris. For decades, the vaccine has been administered to millions of children, helping to prevent severe and life-threatening complications of measles, mumps and rubella. Serious side effects of the vaccine, including seizures, are rare.
Over the years, multiple large-scale studies have debunked claims linking the MMR vaccine and autism. Studies have also disproven connections between autism and vaccines containing thimerosal, a preservative often used in combination vaccines, according to the U.S. Food & Drug Administration.
Heads up: A group of newborns were exposed to measles. Can babies be protected?
When should you receive the MMR vaccine?
The MMR vaccine is administered in two doses, usually during childhood. One dose provides 93% protection against measles, and two doses provide 97% protection, says Dr. Peter Chin-Hong, a professor of medicine and infectious disease specialist at UCSF Health. When you receive two doses of MMR, you are considered to be fully immunized against measles.
Healthcare providers prioritize administering the MMR vaccine during early childhood for two primary reasons, Harris says. First, measles, mumps and rubella are highly infectious, and spread easily in congregant settings, such as daycares and summer camps. Second, children are particularly vulnerable to developing severe symptoms. Unvaccinated children under the age of 5 have an elevated risk of experiencing dangerous complications due to measles, including pneumonia, encephalitis (brain inflammation), loss of sight or hearing and death, per the CDC.
It is recommended that babies receive their first dose of the MMR vaccine when they're between 12 and 15 months. The second MMR dose is usually administered when a child is 4 to 6 years old. In the case of a measles outbreak, or international travel, a baby can receive one dose of MMR when they are as young as six months old. They will still need to receive another two doses of the vaccine within the CDC-recommended time frames after they turn 1, says Chin-Hong.
If you weren't vaccinated against measles as a young child, you can still receive the MMR vaccine later in life, note Chin-Hong and Harris. Two doses of MMR will yield the same level of protection against measles, even if you've previously been exposed to the disease. It's important to note certain groups of people, including pregnant women and some immunocompromised individuals, aren't able to receive the MMR vaccine. This is the minority of patients, and a healthcare provider can help determine your eligibility for the vaccine.
If you're unsure whether you're protected against measles, check your vaccination records. It's possible some individuals may need to be revaccinated, although this isn't the case for most people. For example, if you find you were vaccinated between 1963 and 1967 and received the killed measles vaccine, the CDC recommends you receive at least one dose of a live attenuated measles vaccine.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Magazine
27 minutes ago
- Time Magazine
Trump's First Surgeon General: RFK Jr. Purging the CDC Advisory Committee Will Put Lives at Risk
When Secretary Robert F. Kennedy Jr. began his tenure as Health and Human Services Secretary, he pledged, 'We won't take away anyone's vaccines.' However, recent policy changes under his leadership—coupled with the unprecedented dismissal of all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP) on June 9—have proven that statement false, raising grave concerns for our nation's COVID-19 response and broader vaccine policies. These shifts not only jeopardize public health but also threaten to erode trust in our health institutions at a critical time. In May 2025, the Food and Drug Administration (FDA) introduced a new COVID-19 vaccine framework, limiting access to updated vaccines for Americans aged 65 and older or those with specific risk factors. Furthermore, Secretary Kennedy announced that the Centers for Disease Control and Prevention (CDC) would no longer recommend COVID-19 vaccines for 'healthy' children or pregnant women—bypassing the standard ACIP review process. Compounding these changes, the abrupt removal of ACIP's entire panel of independent experts, who have guided evidence-based vaccine policy for decades, risks destabilizing a cornerstone of public health. These actions collectively restrict access to a vital tool for saving lives and undermine confidence in our health systems. During my tenure as Surgeon General under the first Trump administration, we faced significant public health challenges, from addressing the opioid epidemic by increasing access to Naloxone to launching Operation Warp Speed for the COVID-19 vaccine development effort. The vaccines developed under Trump's first term have proven to be one of our most effective defenses against COVID-19; yet, the current administration's new policies limit their availability, potentially leaving millions vulnerable. The dismissal of ACIP's experts—without a clear plan for replacing them with qualified scientists—further jeopardizes trust in the institutions tasked with protecting Americans. The major flaw in the new vaccine framework is its narrow assessment of risk. Although the immediate dangers of COVID-19 have lessened, it remains a leading cause of death and hospitalization, claiming nearly 50,000 lives in the U.S. in 2024—more than breast cancer or car accidents. The fact is, 75% of Americans have risk factors, such as obesity or diabetes, that increase their vulnerability to severe COVID outcomes. However, the burden is now placed on individuals to self-identify as high risk, creating confusion and inconsistency in access. Unlike other countries with centralized systems for identifying at-risk individuals, the U.S. expects patients—many of whom lack easy access to healthcare—to navigate eligibility alone. Risk assessment should also consider individual circumstances beyond underlying health conditions. A 58-year-old bus driver or healthcare worker faces significantly greater exposure than someone working remotely. By limiting vaccines to specific groups based solely on preexisting health status, the policy overlooks these critical contextual differences. Secretary Kennedy's team argues that there is insufficient evidence to support updated COVID-19 vaccines for healthy Americans under 65, but this claim is flatly unfounded. Years of real-world data demonstrate that vaccines save lives and reduce hospitalizations across all age groups. During the 2023 to 2024 fall and winter season, 95% of those hospitalized for COVID had not received an updated vaccine. While the administration cites other countries' more restrictive vaccine policies, such comparisons ignore the unique health landscape in the U.S., which includes higher obesity rates, worse maternal health outcomes, and uneven healthcare access. The policy also neglects the issue of Long COVID, which affects millions with debilitating symptoms lasting months or years. Though older adults are at higher risk for severe acute infections, Long COVID disproportionately impacts adults aged 35 to 49—and children are also affected. Vaccination reduces the risk of developing Long COVID, an essential reason many healthy individuals choose to stay up-to-date with their vaccines. Particularly concerning is the decision to end COVID vaccine recommendations for 'healthy' pregnant women, which contradicts the FDA's own guidance. Pregnant women face heightened risks of severe COVID outcomes, including death, pre-eclampsia, and miscarriage. Vaccination during pregnancy is crucial—not just for maternal health but also for protecting infants under six months, who cannot be vaccinated and rely on maternal antibodies for protection. Decades of research confirm that vaccines, including COVID vaccines, safely transfer antibodies to newborns, lowering their risk of severe illness. The dismissal of ACIP's members amplifies these concerns. ACIP has been a trusted, science-driven body that ensures vaccines are safe and effective, saving countless lives through its transparent recommendations. Its members, rigorously vetted for expertise and conflicts of interest, provide independent guidance critical to public health. Removing them without clear evidence of misconduct risks replacing qualified scientists with less experienced voices. This move fuels vaccine hesitancy and skepticism about public health decisions, particularly when paired with the bypassing of ACIP's review process for the new COVID vaccine policies. These changes create uncertainty about who can access vaccines. Without clear CDC recommendations, insurance companies may impose their own coverage criteria, potentially increasing costs for a vaccine that was previously free for most Americans. Healthcare providers, lacking federal guidance and ACIP's expertise, may struggle to advise patients, leading to a confusing and inequitable system that limits choice—hardly the 'medical freedom' Secretary Kennedy claims to champion. Ultimately, these actions threaten to erode trust in public health. FDA officials argue the new framework enhances transparency, yet bypassing ACIP's review and dismissing its members undermines that aim. Extensive data demonstrate that updated vaccines lower hospitalization and death rates, yet this evidence was sidelined. Such actions breed skepticism, making it harder to unite Americans around shared health goals. The stakes are high, but a better path is possible. Restoring trust requires transparent, evidence-based policymaking that prioritizes access to life-saving tools. I urge Secretary Kennedy and the administration to reconsider this framework, reinstate ACIP's role in vaccine policy, and ensure any new appointees are qualified, independent experts. If concerns about ACIP exist, they should be addressed through reform, not dissolution. Healthcare providers and community leaders must also educate patients about vaccination benefits, particularly for vulnerable groups like pregnant women and those with high exposure. Individuals can take action by staying informed, discussing vaccination with their doctors, and advocating for clear, equitable access to vaccines. By working together—government, providers, and citizens—we can protect lives, reduce the burden of Long COVID, and rebuild confidence in our public health system. We must seize this opportunity to unite around science and ensure a healthier, safer, and prosperous future for all Americans.
Yahoo
an hour ago
- Yahoo
It Sure Seems Like One Key GOP Vote Regrets Appointing RFK Jr.
Senator Bill Cassidy promised the American people that Robert F. Kennedy Jr. would not make any changes to the CDC's vaccine advisory committee when he cast his decisive confirmation vote for the HHS secretary. But on Monday RFK Jr. scrapped the board entirely, leaving Cassidy scrambling to explain himself and his vote. 'Of course, now the fear is that the ACIP will be filled up with people who know nothing about vaccines except suspicion,' Cassidy posted on X after Kennedy explained his rationale in a Wall Street Journal op-ed. 'I've just spoken with Secretary Kennedy, and I'll continue to talk with him to ensure this is not the case.' When asked what he said specifically to Kennedy to 'ensure' that the immunization advisory committee wouldn't be run by anti-vaxers, Cassidy went mum. 'I'd rather just characterize it as: we had a conversation,' he told Semafor's Burgess Everett on Tuesday. When Burgess asked if Cassidy was 'still comfortable' with voting to confirm RFK Jr. in February, Cassidy replied 'I'd rather not comment on that.' During the confirmation process Cassidy explicitly guaranteed that 'If confirmed, [RFK Jr.] will maintain the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices without changes.' Either Cassidy was lying, or RFK Jr. was lying to Cassidy. Now all of the other promises that Cassidy made on RFK's behalf—like not making false claims about vaccines causing autism, or even appearing before Congress on a quarterly basis—are moot. Cassidy claimed that he studied his decision to confirm Kennedy 'exhaustively' and took it 'very seriously.' It's clear that Cassidy's words meant nothing as Kennedy guts a key institution of our national health apparatus.
CNN
2 hours ago
- CNN
Former WH Covid Czar slams RFK Jr.'s firing of vaccine advisory panel
Dr. Ashish Jha, Dean of Brown University's School of Public Health, tells CNN's Wolf Blitzer why he calls HHS Secretary Kennedy's reasoning for firing all members of the CDC's vaccine advisory committee "nonsense."
